Winton Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.5M | Buy |
44,405
+35,432
| +395% | +$7.36M | 0.34% | 67 |
|
|
2026
Q1 | $1.9M | Buy |
+8,973
| New | +$1.93M | 0.07% | 343 |
|
|
2023
Q4 | – | Sell |
-120,508
| Closed | -$10.5M | – | 749 |
|
|
2023
Q3 | $10.5M | Sell |
120,508
-165,858
| -58% | -$15M | 0.86% | 16 |
|
|
2023
Q2 | $27.1M | Buy |
+286,366
| New | +$24.2M | 2.27% | 6 |
|
|
2023
Q1 | – | Sell |
-10,808
| Closed | -$831K | – | 967 |
|
|
2022
Q4 | $831K | Buy |
10,808
+4,444
| +70% | +$338K | 0.05% | 472 |
|
|
2022
Q3 | $424K | Sell |
6,364
-311
| -5% | -$19.7K | 0.03% | 687 |
|
|
2022
Q2 | $349K | Buy |
+6,675
| New | +$379K | 0.02% | 776 |
|
|
2020
Q2 | – | Sell |
-187,036
| Closed | -$8.97M | – | 1462 |
|
|
2020
Q1 | $8.97M | Buy |
+187,036
| New | +$9.71M | 0.24% | 85 |
|
|
2018
Q4 | – | Sell |
-4,008
| Closed | -$216K | – | 880 |
|
|
2018
Q3 | $216K | Sell |
4,008
-135
| -3% | -$6.91K | ﹤0.01% | 943 |
|
|
2018
Q2 | $202K | Sell |
4,143
-936
| -18% | -$53.1K | 0.01% | 984 |
|
|
2018
Q1 | $318K | Sell |
5,079
-1,064
| -17% | -$73K | 0.01% | 953 |
|
|
2017
Q4 | $376K | Sell |
6,143
-3,195
| -34% | -$198K | 0.01% | 555 |
|
|
2017
Q3 | $625K | Sell |
9,338
-123,394
| -93% | -$8.72M | 0.02% | 501 |
|
|
2017
Q2 | $10.3M | Sell |
132,732
-133,520
| -50% | -$10.1M | 0.3% | 101 |
|
|
2017
Q1 | $21.7M | Buy |
266,252
+29,191
| +12% | +$2.3M | 0.59% | 49 |
|
|
2016
Q4 | $17.1M | Sell |
237,061
-438,138
| -65% | -$31.7M | 0.56% | 53 |
|
|
2016
Q3 | $52.5M | Buy |
675,199
+27,542
| +4% | +$2.23M | 0.9% | 19 |
|
|
2016
Q2 | $50.5M | Buy |
647,657
+244,431
| +61% | +$19.5M | 0.83% | 24 |
|
|
2016
Q1 | $33M | Sell |
403,226
-629,389
| -61% | -$51.2M | 0.36% | 115 |
|
|
2015
Q4 | $92.2M | Sell |
1,032,615
-99,591
| -9% | -$8.46M | 0.82% | 20 |
|
|
2015
Q3 | $87M | Buy |
1,132,206
+371,209
| +49% | +$31M | 0.69% | 21 |
|
|
2015
Q2 | $63.7M | Buy |
760,997
+640,248
| +530% | +$56.5M | 0.58% | 39 |
|
|
2015
Q1 | $10.9M | Sell |
120,749
-326,255
| -73% | -$28.1M | 0.09% | 286 |
|
|
2014
Q4 | $36.1M | Sell |
447,004
-661,755
| -60% | -$52.3M | 0.45% | 64 |
|
|
2014
Q3 | $83.1M | Sell |
1,108,759
-389,574
| -26% | -$28.3M | 0.59% | 20 |
|
|
2014
Q2 | $103M | Buy |
+1,498,333
| New | +$102M | 0.7% | 8 |
|
Other funds holding CAH
Winton Group's CAH Position: Q2 2026 in Review
Winton Group increased its Cardinal Health (CAH) stake by 395% in Q2 2026, buying an estimated $7.36M and bringing the position to 44,405 shares worth $10.5M. The position accounts for 0.34% of the portfolio, ranked #67.
Winton Group first reported a position in CAH in Q2 2014 and has held it in 26 quarters since. The position peaked at $103M in Q2 2014. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Winton Group held 44,405 shares of Cardinal Health worth $10.5M as of Q2 2026.
- Winton Group bought 35,432 Cardinal Health shares in Q2 2026, an estimated $7.36M.
- Cardinal Health made up 0.34% of Winton Group's portfolio in Q2 2026, its #67 holding.
- Winton Group first reported a position in Cardinal Health in Q2 2014 and has held it in 26 quarters since.
- Winton Group's Cardinal Health position peaked at $103M in Q2 2014.
- 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.